NovMetaPharma Co., Ltd. (XKON:229500)
South Korea
· Delayed Price · Currency is KRW
8,890.00
-250.00 (-2.74%)
At close: Mar 9, 2026
NovMetaPharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2014 | FY 2013 |
| Mar '26 Mar 6, 2026 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
| Net Debt / Equity Ratio | -0.66 | -0.66 | -0.64 |
| Net Debt / EBITDA Ratio | 46.49 | 46.49 | -17.63 |
| Net Debt / FCF Ratio | 13.25 | 13.25 | -8.57 |
| Asset Turnover | 0.33 | 0.33 | - |
| Inventory Turnover | 3.01 | 3.01 | - |
| Quick Ratio | 28.62 | 28.62 | 18.32 |
| Current Ratio | 32.26 | 32.26 | 26.50 |
| Return on Equity (ROE) | 10.84% | 10.84% | - |
| Return on Assets (ROA) | -1.96% | -1.96% | - |
| Return on Capital Employed (ROCE) | -2.30% | -2.30% | 2.10% |
| Buyback Yield / Dilution | - | -21.30% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.